Ionis Pharmaceuticals, Inc. (IONS) Ownership

$33.51

$0.05 (0.15%)
Last update: 04:00 PM EST
Day's range
$32.58
Day's range
$33.88

Ionis Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/12/2025 23.61 M $712.42 M   4.07% 14.88%
VANGUARD GROUP INC 05/09/2025 16.38 M $494.30 M   -0.54% 10.32%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/14/2025 16.18 M $488.02 M   14.16% 10.19%
CAPITAL WORLD INVESTORS 05/12/2025 12.36 M $372.96 M   7.82% 7.79%
BLACKROCK, INC. 05/02/2025 11.26 M $339.85 M   -3.44% 7.10%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 8.42 M $253.92 M   -2.95% 5.30%
BELLEVUE GROUP AG 05/14/2025 7.85 M $236.93 M   -0.20% 4.95%
STATE STREET CORP 05/15/2025 4.85 M $146.18 M   -10.71% 3.05%
DEEP TRACK CAPITAL, LP 05/15/2025 4.56 M $137.70 M   136.01% 2.88%
CITADEL ADVISORS LLC 05/15/2025 3.48 M $104.99 M   60.67% 2.19%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 3.27 M $98.51 M   -14.68% 2.06%
TWEEDY, BROWNE CO LLC 05/15/2025 2.98 M $90.01 M   -8.17% 1.88%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 2.84 M $85.80 M   5.79% 1.79%
ORBIMED ADVISORS LLC 05/15/2025 2.54 M $76.64 M   -9.84% 1.60%
TWO SIGMA ADVISERS, LP 05/15/2025 2.09 M $63.12 M   55.05% 1.32%
BVF INC/IL 05/15/2025 1.91 M $57.73 M   100.00% 1.21%
TWO SIGMA INVESTMENTS, LP 05/15/2025 1.69 M $50.86 M   82.96% 1.06%
MACQUARIE GROUP LTD 05/15/2025 1.67 M $50.30 M   -5.79% 1.05%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 1.44 M $43.55 M   -2.55% 0.91%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 05/14/2025 1.20 M $36.10 M   10.74% 0.75%
MORGAN STANLEY 05/15/2025 1.14 M $34.52 M   -13.97% 0.72%
TD ASSET MANAGEMENT INC 05/07/2025 1.10 M $33.20 M   4.81% 0.69%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 1.08 M $32.45 M   291.13% 0.68%
GROUPAMA ASSET MANAGMENT 05/14/2025 1.07 M $18.23 M   5.11% 0.67%
HUDSON BAY CAPITAL MANAGEMENT LP 05/14/2025 1.05 M $31.68 M   27.85% 0.66%
ARK INVESTMENT MANAGEMENT LLC 05/07/2025 1.00 M $30.19 M   -2.41% 0.63%
CANDRIAM S.C.A. 05/14/2025 993.70 K $29.98 M   16.93% 0.63%
INVESCO LTD. 05/12/2025 874.83 K $26.39 M   10.94% 0.55%
NORTHERN TRUST CORP 05/13/2025 834.85 K $25.19 M   -0.65% 0.53%
BANK OF MONTREAL /CAN/ 05/13/2025 782.84 K $23.62 M   150.79% 0.49%
BANK OF AMERICA CORP /DE/ 05/15/2025 767.43 K $23.15 M   81.49% 0.48%
CAMBER CAPITAL MANAGEMENT LP 05/15/2025 725.00 K $21.87 M   16.00% 0.46%
UBS ASSET MANAGEMENT AMERICAS INC 05/19/2025 659.44 K $19.90 M   6.42% 0.42%
GOLDMAN SACHS GROUP INC 05/16/2025 652.52 K $19.69 M   72.53% 0.41%
MILLENNIUM MANAGEMENT LLC 05/15/2025 635.37 K $19.17 M   -17.93% 0.40%
PICTET ASSET MANAGEMENT HOLDING SA 05/05/2025 618.55 K $19.25 M   -0.36% 0.39%
ROYAL BANK OF CANADA 05/15/2025 616.08 K $18.59 M   -4.22% 0.39%
PINNACLE ASSOCIATES LTD 05/06/2025 608.52 K $18.36 M   11.12% 0.38%
AXA S.A. 05/15/2025 566.49 K $17.09 M   -6.42% 0.36%
SCHONFELD STRATEGIC ADVISORS LLC 05/15/2025 560.36 K $16.91 M   50.89% 0.35%
BANK OF NEW YORK MELLON CORP 04/29/2025 544.63 K $16.43 M   -11.60% 0.34%
EVERSEPT PARTNERS, LP 05/15/2025 517.02 K $15.60 M   140.53% 0.33%
TEACHER RETIREMENT SYSTEM OF TEXAS 04/28/2025 500.45 K $15.10 M   660.66% 0.32%
ABRDN PLC 05/13/2025 446.20 K $13.50 M   11.13% 0.28%
CITIGROUP INC 05/12/2025 426.48 K $12.87 M   152.12% 0.27%
JPMORGAN CHASE & CO 05/12/2025 421.51 K $12.72 M   1.34% 0.27%
C WORLDWIDE GROUP HOLDING A/S 05/05/2025 400.00 K $12.07 M   0.00% 0.25%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 05/15/2025 377.20 K $11.38 M   19.01% 0.24%
AMERIPRISE FINANCIAL INC 05/14/2025 360.19 K $10.87 M   -7.04% 0.23%
BAKER BROS. ADVISORS LP 05/15/2025 357.92 K $10.80 M   0.00% 0.23%

Ionis Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 516 institutional investors and hedge funds held shares of Ionis Pharmaceuticals, Inc.. The most heavily invested institutionals were:

FMR LLC: 23.61 M

VANGUARD GROUP INC: 16.38 M

T. Rowe Price Investment Management, Inc.: 16.18 M

Capital World Investors: 12.36 M

BlackRock, Inc.: 11.26 M

WELLINGTON MANAGEMENT GROUP LLP: 8.42 M

104.79% of Ionis Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 201.15 M shares in the last 24 months. This purchase volume represents approximately $6.74 B in transactions.